Thyrocare Divests 100% Stake in Nueclear Healthcare for Rs. 141.40 Crore
Thyrocare Technologies Ltd 路 Others (Uncategorized) 路 30 Oct 2026, 10:58 pm
Thyrocare Divests 100% Stake in Nueclear Healthcare for Rs. 141.40 Crore Thyrocare Technologies signed a Share Purchase Agreement on 30th Oct'26 to sell its 100% equity stake (1.11 crore shares) in wholly owned subsidiary Nueclear Healthcare Limited to Trovera Healthcare for ~Rs. 141.40 crore. Shareholders approved the transaction via special resolution on 29th Oct'26. The consideration comprises Rs. 81.90 crore in cash (subject to working capital adjustments) and Rs. 59.50 crore via 42,500 Compulsorily Convertible Preference Shares of Trovera at Rs. 14,000 each. The transaction is non-related party and subject to customary closing conditions.
Original exchange filing (PDF)
More announcements from Thyrocare Technologies Ltd
- Please find the enclosed announcement. 路 06 Nov 2026
- Please find the enclosed intimation. 路 06 Nov 2026
- Please find attached the Earnings Call Transcript held on October 29, 2026 路 02 Nov 2026
- Audio Recording of Earnings Conference Call for the Quarter and Half Year Ended September 30, 2026 路 30 Oct 2026
- Please find attached the Investor Presentation on the unaudited financial results (standalone and consolidated) for the quarter and half year ended on September 30, 2026 路 29 Oct 2026
- Please find attached the Press Release on the unaudited financial results (Standalone and Consolidated) for the quarter and half year ended on September 30, 2026 路 29 Oct 2026
- Please find enclosed the unaudited standalone and consolidated financial results of the Company for the quarter and half year ended on September 30, 2026 路 29 Oct 2026
- Please find enclosed outcome of the Board Meeting held on October 29, 2026, inter alia, approving the unaudited financial results for the quarter and half year ended September 30, 2026 .... 路 29 Oct 2026
